This work also found that NR activity in the Atp7b-/- mouse is improved by dietary Zn supplementation, and verified that WD patients with high hepatic Cu have gene expression changes consistent with metabolic NR disruption [18]. This evidence concerns the gene ATP7B and Wilson disease.